Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for Postendodontic Pain and IANB Success
NCT03199482Phase 1Unknown
- Sponsor
- Cairo University
- Start
- Jul 2017
- Primary completion
- Oct 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in irreversible pulpitis and postoperative pain comparing Drug dexamethasone with Placebo (2 arms). Primary endpoint: Postoperative pain at 48 hours. Status: unknown.
02
Drugs
dexamethasone
03
Conditions
irreversible pulpitispostoperative pain
Beyond the preview
Go deeper on NCT03199482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03199482.